Proteins as binding targets of isothiocyanates in cancer prevention

Carcinogenesis

Volumn 32, Issue 10, 2011, Pages 1405-1413

  Mi, Lixin ^a   di Pasqua, Anthony J ^a   Chung, Fung Lung ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BENZYL ISOTHIOCYANATE; BREAST CANCER RESISTANCE PROTEIN; CELL CYCLE PROTEIN; CYTOCHROME P450; GLUTATHIONE; ISOTHIOCYANIC ACID DERIVATIVE; PHENETHYL ISOTHIOCYANATE; PROTEIN KINASE C; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SULFORAPHANE; TUBULIN;

APOPTOSIS; BINDING SITE; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CANCER RISK; CHEMOPROPHYLAXIS; DIETARY INTAKE; DRUG EFFICACY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TARGETING; REVIEW; TUMOR GROWTH; TUMOR PROMOTION;

ANIMALS; ANTICARCINOGENIC AGENTS; HUMANS; ISOTHIOCYANATES; NEOPLASMS; PROTEIN BINDING; PROTEINS;

EID: 80053154634     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr111     Document Type: Review

References (94)

1. WHO. (2004) IARC Handbook on Cancer Prevention 9. IARC, Lyon.
2. London,S.J. et al. (2000) Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet, 356, 724-729.
3. Mi,L. et al. (2007) The role of protein binding in induction of apoptosis by phenethyl isothiocyanate and sulforaphane in human non-small lung cancer cells. Cancer Res., 67, 6409-6416.
4. Kassie,F. et al. (2000) Genotoxic effects of allyl isothiocyanate (AITC) and phenethyl isothiocyanate (PEITC). Chem. Biol. Interact., 127, 163-180.
5. Palumaa,P. (2009) Biological redox switches. Antioxid. Redox Signal, 11, 981-983.
6. Singh,S.V. et al. (2005) Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J. Biol. Chem., 280, 19911-19924.
7. Mi,L. et al. (2008) Covalent binding to tubulin by isothiocyanates. A mechanism of cell growth arrest and apoptosis. J. Biol. Chem., 283, 22136-22146.
8. Cross,J.V. et al. (2009) Nutrient isothiocyanates covalently modify and inhibit the inflammatory cytokine macrophage migration inhibitory factor (MIF). Biochem. J., 423, 315-321.
9. Ouertatani-Sakouhi,H. et al. (2009) A new class of isothiocyanate-based irreversible inhibitors of macrophage migration inhibitory factor. Biochemistry, 48, 9858-9870.
10. Brown,K.K. et al. (2009) Direct modification of the proinflammatory cytokine macrophage migration inhibitory factor by dietary isothiocyanates. J. Biol. Chem., 284, 32425-32433.
11. Zhang,Y. et al. (1995) Reversible conjugation of isothiocyanates with glutathione catalyzed by human glutathione transferases. Biochem. Biophys. Res. Commun., 206, 748-755.
12. Hayakawa,T. (1977) Glutathione S-transferases in the metabolism of foreign compounds. Ecotoxicol. Environ. Saf., 1, 305-309.
13. Zhang,Y.S. et al. (1998) Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic Phase 2 enzymes. Cancer Res., 58, 4632-4639.
14. Eklind,K.I. et al. (1990) Distribution and metabolism of the natural anticarcinogen phenethyl isothiocyanate in A/J mice. Carcinogenesis, 11, 2033-2036.
15. Shapiro,T.A. et al. (1998) Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables. Cancer Epidemiol. Biomarkers Prev., 7, 1091-1100.
16. Mi,L. et al. (2010) A cautionary note on using N-acetylcysteine as an antagonist to assess isothiocyanate-induced ROS-mediated apoptosis. Anal. Biochem., 405, 269-271.
17. Mi,L. et al. (2010) Isothiocyanates inhibit proteasome activity and proliferation of multiple myeloma cells. Carcinogenesis, 32, 216-223.
18. Zhang,Y. (2000) Role of glutathione in the accumulation of anticarcinogenic isothiocyanates and their glutathione conjugates by murine hepatoma cells. Carcinogenesis, 21, 1175-1183.
19. Podhradský,D. et al. (1979) Reaction of Cysteine, its derivatives, glutathione, coenzyme A, and dihydrolipoic acid with isothiocyanates. Experientia, 35, 154-155.
20. Jiao,D. et al. (1996) Inhibition of N-nitrosodimethylamine demethylase in rat and human liver microsomes by isothiocyanates and their glutathione, L-cysteine, and N-acetyl-L-cysteine conjugates. Chem. Res. Toxicol., 9, 932-938.
21. Conaway,C.C. et al. (2005) Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. Cancer Res., 65, 8548-8557.
22. Tang,L. et al. (2006) The principal urinary metabolites of dietary isothiocyanates, N-acetylcysteine conjugates, elicit the same anti-proliferative response as their parent compounds in human bladder cancer cells. Anticancer Drugs, 17, 297-305.
23. Drobnica,L. et al. (1976) Use of isothiocyanates as "reporter" groups in modification of enzymes. In Fox,J.L. et al. (eds) Protein Structure and Evolution, Dekker, New York, NY, pp. 105-115.
24. Murthy,N.V.K.K. et al. (1986) Interaction of allyl isothiocyanate with mustard 12S protein. J. Agric. Food Chem., 34, 448-452.
25. Snyder,G.H. et al. (1981) Electrostatic influence of local cysteine environments on disulfide exchange kinetics. Biochemistry, 20, 6509-6519.
26. Soares,T.A. et al. (2002) Internal dynamics and ionization states of the macrophage migration inhibitory factor: comparison between wild-type and mutant forms. Biopolymers, 65, 313-323.
27. Nagahara,N. et al. (2009) Protein cysteine modifications: (2) reactivity specificity and topics of medicinal chemistry and protein engineering. Curr. Med. Chem., 16, 4490-4501.
28. Doorn,J.A. et al. (2002) Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal. Chem. Res. Toxicol., 15, 1445-1450.
29. Hollenberg,P.F. et al. (2008) Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications. Chem. Res. Toxicol., 21, 189-205.
30. Rando,R.R. (1984) Mechanism-based enzymes inactivators. Pharmacol. Rev., 36, 111-142.
31. Kent,U.M. et al. (2001) Spectral studies of tert-butyl isothiocyanate-inactivated P450 2E1. Biochemistry, 40, 7253-7261.
32. von Weymarn,L.B. et al. (2006) Effects of benzyl and phenethyl isothiocyanate on P450s 2A6 and 2A13: potential for chemoprevention in smokers. Carcinogenesis, 27, 782-790.
33. Lee,M.S. (1996) Enzyme induction and comparative oxidative desulfuration of isothiocyanates to isocyanates. Chem. Res. Toxicol., 9, 1072-1078.
34. Egner,P.A. et al. (2008) Quantification of sulforaphane mercapturic acid pathway conjugates in human urine by high-performance liquid chromatography and isotope-dilution tandem mass spectrometry. Chem. Res. Toxicol., 21, 1991-1996.
35. Kobayashi,A. et al. (2006) Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol. Cell. Biol., 26, 221-229.
36. Dinkova-Kostova,A.T. et al. (2002) Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl Acad. Sci. USA, 99, 11908-11913.
37. Tong,K.I. et al. (2006) Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol. Cell. Biol., 26, 2887-2900.
38. Yamamoto,T. et al. (2008) Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol. Cell. Biol., 28, 2758-2770.
39. Kobayashi,M. et al. (2009) The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol. Cell. Biol, 29, 493-502.
40. Li,W. et al. (2009) Molecular mechanisms of Nrf2-mediated antioxidant response. Mol. Carcinog., 48, 91-104.
41. Hong,F. et al. (2005) Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane. Chem. Res. Toxicol., 18, 1917-1926.
42. Li,W. et al. (2005) Nrf2 possesses a redox-insensitive nuclear export signal overlapping with the leucine zipper motif. J. Biol. Chem., 280, 28430-28438.
43. Tseng,E. et al. (2002) Effect of organic isothiocyanates on the P-glycoproteinand MRP1-mediated transport of daunomycin and vinblastine. Pharm. Res., 19, 1509-1515.
44. Ji,Y. et al. (2004) Effect of organic isothiocyanates on breast cancer resistance protein (ABCG2)-mediated transport. Pharm. Res., 21, 2261-2269.
45. Ji,Y. et al. (2005) Membrane transport of dietary phenethyl isothiocyanate by ABCG2 (breast cancer resistance protein). Mol. Pharm., 2, 414-419.
46. Karlish,S.J. (1979) Na+, K+-ATPase Structure and Kinetics. In Skou, J. C. and Norby J. G. (eds) Academic Press, London, UK, pp. 115-128.
47. Breier,A. et al. (1995) Inhibition of (Na/K)-ATPase by electrophilic substances: functional implications. Mol. Cell. Biochem., 147, 187-192.
48. Carilli,C.T. et al. (1982) The active site structure of Na+- andK+-stimulated ATPase. Location of a specific fluorescein isothiocyanate reactive site. J. Biol. Chem., 257, 5601-5606.
49. Taniguchi,K. et al. (1988) Microenvironment of two different extrinsic fluorescence probes in Na+ K1-ATPase changes out of phase during sequential appearance of intermediates. J. Biol. Chem., 263, 12943-12947.
50. Breier,A. et al. (2000) "Lysine is the Lord", thought some scientists in regard to the group interacting with fluorescein isothiocyanate in ATPbinding sites of P-type ATPases but, is it not cysteine? Gen. Physiol. Biophys., 19, 253-263.
51. Kubala,M. et al. (2003) Eight amino acids form the ATP recognition site of Na(+)/K(+)-ATPase. Biochemistry, 42, 6446-6452.
52. Wilson,L. et al. (1999)Modulation of microtubule dynamics by drugs: a paradigm for the actions of cellular regulators. Cell Struct. Funct., 24, 329-335.
53. Mi,L. et al. (2009) Cancer preventive isothiocyanates induce selective degradation of cellular alpha- and beta-tubulins by proteasomes. J. Biol. Chem., 284, 17039-17051.
54. Mi,L. et al. (2009) Aggresome-like structure induced by isothiocyanates is novel proteasome-dependent degradation machinery. Biochem. Biophys. Res. Commun., 388, 456-462.
55. Hinman,A. et al. (2006) TRP channel activation by reversible covalent modification. Proc. Natl. Acad. Sci. USA, 103, 19564-19568.
56. Chen,Y.R. et al. (2002) Phenylethyl isothiocyanate induces apoptotic signaling via suppressing phosphatase activity against c-Jun N-terminal kinase. J. Biol. Chem., 277, 39334-39342.
57. Xiao,D. et al. (2004) Proteasome-mediated degradation of cell division cycle 25C and cyclin-dependent kinase 1 in phenethyl isothiocyanateinduced G2-M-phase cell cycle arrest in PC-3 human prostate cancer cells. Mol. Cancer Ther., 3, 567-575.
58. Singh,S.V. et al. (2004) Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J. Biol. Chem., 279, 25813-25822.
59. Cross,J.V. et al. (2007) The isothiocyanate class of bioactive nutrients covalently inhibit the MEKK1 protein kinase. BMC Cancer, 7, 183.
60. Kim,J.H. et al. (2006) Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin. Carcinogenesis, 27, 475-482.
61. Nomura,T. et al. (2009) Alkyl isothiocyanates suppress epidermal growth factor receptor kinase activity but augment tyrosine kinase activity. Cancer Epidemiol., 33, 288-292.
62. Mukherjee,S. et al. (2009) Isothiocyanates sensitize the effect of chemotherapeutic drugs via modulation of protein kinase C and telomerase in cervical cancer cells. Mol. Cell. Biochem., 330, 9-22.
63. Hu,Y. et al. (2007) Glutathione- and thioredoxin-related enzymes are modulated by sulfur-containing chemopreventive agents. Biol. Chem., 388, 1069-1081.
64. Krauth-Siegel,R.L. et al. (1998) Role of active site tyrosine residues in catalysis by human glutathione reductase. Biochemistry, 37, 13968-13977.
65. Lee,S.R. et al. (2000) Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc. Natl Acad. Sci. USA, 97, 2521-2526.
66. Matthews,C.P. et al. (2007) AP-1 a target for cancer prevention. Curr. Cancer Drug Targets, 7, 317-324.
67. Dickinson,S.E. et al. (2009) Inhibition of activator protein-1 by sulforaphane involves interaction with cysteine in the cFos DNA-binding domain: implications for chemoprevention of UVB-induced skin cancer. Cancer Res., 69, 7103-7110.
68. Myzak,M.C. et al. (2004) A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res., 64, 5767-5774.
69. Sahu,R.P. et al. (2009) The role of STAT-3 in the induction of apoptosis in pancreatic cancer cells by benzyl isothiocyanate. J. Natl Cancer Inst., 101, 176-193.
70. Gong,A. et al. (2009) Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells. Mol. Nutr. Food Res., 53, 878-886.
71. Hahm,E.R. et al. (2010) Sulforaphane inhibits constitutive and interleukin-6-induced activation of signal transducer and activator of transcription 3 in prostate cancer cells. Cancer Prev. Res., 3, 484-494.
72. Wang,X. et al. (2010) Selective. depletion of mutant p53 by cancer chemopreventive isothiocyanates and its structure-activity relationships. J. Med. Chem. in press.
73. Edman,P. (1950) Method for the determination of the amino acid sequence in peptides. Acta Chem. Scand., 4, 283-293.
74. Nakamura,T. et al. (2009) Covalent modification of lysine residues by allyl isothiocyanate in physiological conditions: plausible transformation of isothiocyanate from thiol to amine. Chem. Res. Toxicol., 22, 536-542.
75. Kumar,A. et al. (2010) New biomarkers for monitoring the levels of isothiocyanates in humans. Chem. Res. Toxicol., 23, 756-765.
76. Campa,M.J. et al. (2003) Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer. Cancer Res., 63, 1652-1656.
77. Stamps,S.L. et al. (1998) Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor. Biochemistry, 37, 10195-10202.
78. Rose,P. et al. (2005) Beta-phenylethyl and 8-methylsulphinyloctyl isothiocyanates, constituents of watercress, suppress LPS induced production of nitric oxide and prostaglandin E2 in RAW 264.7 macrophages. Nitric Oxide, 12, 237-243.
79. Prawan,A. et al. (2009) Anti-NF-kappaB and anti-inflammatory activities of synthetic isothiocyanates: effect of chemical structures and cellular signaling. Chem. Biol. Interact., 179, 202-211.
80. Wallace,D.C. (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet., 39, 359-407.
81. Schumacker,P.T. (2006) Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell, 10, 175-176.
82. Nakamura,Y. et al. (2002) Involvement of the mitochondrial death pathway in chemopreventive benzyl isothiocyanate-induced apoptosis. J. Biol. Chem., 277, 8492-8499.
83. Tang,L. et al. (2005) Mitochondria are the primary target in isothiocyanateinduced apoptosis in human bladder cancer cells. Mol. Cancer Ther., 4, 1250-1259.
84. Xiao,D. et al. (2008) Benzyl isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells. J. Biol. Chem., 283, 30151-30163.
85. Brown,K.K. et al. (2010) Mitochondrial respiratory chain involvement in peroxiredoxin 3 oxidation by phenethyl isothiocyanate and auranofin. FEBS Lett., 584, 1257-1262.
86. Xiao,D. et al. (2010) Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cells. J. Biol. Chem., 285, 26558-26569.
87. Shankar,S. et al. (2008) Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis. Clin. Cancer Res., 14, 6855-6866.
88. Zhang,H. et al. (2008) Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redoxmediated mechanism. Leukemia, 22, 1191-1199.
89. Gan,N. et al. (2010) Sulforaphane activates heat shock response and enhances proteasome activity through up-regulation of Hsp27. J. Biol. Chem., 285, 35528-35536.
90. Tang,L. et al. (2004) Dietary isothiocyanates inhibit the growth of human bladder carcinoma cells. J. Nutr., 134, 2004-2010.
91. Liebes,L. et al. (2000) Phase I safety and pharmacokinetics clinical trials of PEITC in chronic smokers, Proceedings of the American Association for Cancer Research, 42, 834, NCI CN-55120.
92. Conaway,C.C. et al. (1999) Disposition and pharmacokinetics of phenethyl isothiocyanate and 6-phenylhexyl isothiocyanate in F344 rats. Drug Metab. Dispos., 27, 13-20.
93. Akagi,K. et al. (2003) Involvement of toxicity as an early event in urinary bladder carcinogenesis induced by phenethyl isothiocyanate, benzyl isothiocyanate, and analogues in F344 rats. Toxicol. Pathol., 31, 388-396.
94. Liebler,D.C. (2002) Proteomic approaches to characterize protein modifications: new tools to study the effects of environmental exposures. Environ. Health Perspect., 110 (1Suppl), 3-9.